medigraphic.com
Revista Médica Sinergia

2020, Number 07

<< Back Next >>

Revista Médica Sinergia 2020; 5 (07)

Acromegaly

González-Houdelath K

Language: Spanish
References: 20
Page: 1-13
PDF size: 307.74 Kb.


ABSTRACT

Acromegaly is a pathology related to an excessive production of growth hormone. Among its main manifestations there could be found hyperhidrosis, visceromegaly, carpal tunnel syndrome and changes in connective tissue. It is associated with comorbidities such as cardiovascular and pulmonary diseases or neoplasms. The diagnosis is based on the quantification of IGF-1 and with a growth hormone suppression curve with glucose, the latter being the gold standard. There are several types of treatment, which are divided into medical and surgical, which must be individualized for each patient. With the presentation of this clinical case and its respective review based on bibliography, it is intended to report on this pathology not so well known in daily medical practice.


REFERENCES

  1. Katznelson L, Laws E, Melmed S, Molitch M, Murad M, Utz A, Wass J. Acromegaly: An Endocrine Society Clinical Practice Guideline. J ClinEndocrinolMetab. 2014; 99(11):3933–3951. https://doi.org/10.1210/jc.2014-2700

  2. Capatina C, Wass J. Acromegaly. Journal of Endocrinology. 2015; 226(2):141–160. https://doi.org/10.1530/JOE-15-0109

  3. De Herder W. The History of Acromegaly. Neuroendocrinology. 2015. https://doi.org/10.1159/000371808

  4. Dal J, Feldt U, Andersen M, Kristensen L, Laurberg P, Pedersen L, Dekkers O, Sorensen H, Jorgensen JO. Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study. European Journal of Endocrinology. 2016; 175(3): 185-190. https://doi.org/10.1530/EJE-16-0117.

  5. Hossain B, Drake W. Acromegaly. Medicine. 2017; 5(11). doi: http://dx.doi.org/10.1016/j.mpmed.2017.05.011.

  6. Al Dallal S. Acromegaly: a challenging condition to diagnose. International Journal of General Medicine. 2018; 11:337–343. doi: https://doi.org/10.2147/IJGM.S169611

  7. Mora M. Tamizaje para el diagnóstico temprano de Acromegalia en usuarios de la consulta externa de los servicios de endocrinología en tres hospitales nacionales durante el periodo comprendido entre enero del 2016 y julio del 2017. Universidad de Costa Rica. 2018. http://repositorio.sibdi.ucr.ac.cr:8080/jspui/handle/123456789/6123

  8. Melmed S. Acromegaly. N Engl J Med. 2006; 355:2558-2573. https://doi.org/10.1016/j.ecl.2007.10.002

  9. Nuñez N. Acromegalia. Revista Médica de Costa Rica y Centroamérica. 2016; 73(620): 485- 490. https://www.binasss.sa.cr/revistas/rmcc/620/art11.pdf

  10. Dineen R, Stewart P, Sherlock M. Acromegaly. QJM: An International Journal of Medicine. 2017; 110(7): 411-420. https://doi.org/10.1093/qjmed/hcw004

  11. Herra G, Rojas K, Alfaro M. Acromegalia. Rev Cl EMed UCR. 2017; 7(2):11-19. https://www.researchgate.net/deref/http%3A%2F%2Fdx.doi.org%2F10.15517%2Frc_ucrhsjd. v7i2.29125

  12. Chen C, Alpízar D. Las manifestaciones orales de acromegalia. International Journal of Dental Sciences. 2005; 7: 45-48. http://www.redalyc.org/articulo.oa?id=499551910009

  13. Crespo I. Neuropsychological evaluation of patients with acromegaly and Cushing’s syndrome: Long-term effects. [Doctoral Thesis]. Universitat Autónoma de Barcelona. 2016. https://www.tdx.cat/bitstream/handle/10803/392681/icm1de1.pdf?sequence=1&isAllowed=y

  14. Prencipe N, Floriani I, Guaraldi F, DiGiacomo S, Cannavo S, Arnaldi G, Berton A, Torri V, Spinello M, Ghigo E, Grottoli S. ACROSCORE: a new and simple tool for the diagnosis of acromegaly, a rare and underdiagnosed disease. Clinical Endocrinology. 2016; 84: 380–385. https://doi.org/10.1111/cen.12959

  15. Melmed S, Bronstein M, Chanson P, Klibanski A, Casanueva F, Wass J, Strasburger C, Luger A, Clemons D, Giustina A. A Consensus Statement on acromegaly therapeutic outcomes. Nature. 2018; 14: 552-561. https://doi.org/10.1038/s41574-018-0058-5

  16. Hernández S, Obando A, Esquivel M. Biochemical Remission of Acromegalic Patients who Underwent Endoscopic Surgery. Revista Médica de la Universidad de Costa Rica. 2014; 8(2): 44-54. https://doi.org/10.15517/RMU.V8I2.19620

  17. Samson S. Pasireotide in Acromegaly: An Overview of Current Mechanistic and Clinical Data. Neuroendocrinology. 2015. https://doi.org/10.1159/000381460

  18. Giustina A. Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guideline. J Endocrinol Invest. 2014; 37: 1017-1030. https://doi.org/10.1007/s40618-014-0146-x

  19. Silverstein J. Need for improved monitoring in patients with acromegaly. Endocrine Conections. 2015; 4: 59-67. https://doi.org/10.1530/EC-15-0064

  20. Cordido F, García J, Marazuela M, Torres E. Guía práctica de diagnóstico y tratamiento de la acromegalia. Endocrinología y Nutrición. 2012; 60(8). https://doi.org/10.1016/j.endonu.2013.01.012




2020     |     www.medigraphic.com